SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma redeems Zero Coupon Foreign Currency Convertible Bonds (FCCBs) issued in May 2006. The company had issued FCCBs aggregating to $150 million (Tranche A) and after repurchase and cancellation of FCCBs from time to time, the outstanding nominal value of FCCBs of $106.25 million has been paid in full at the redemption price of 146.285% of its principal amount on maturity date - May 17, 2011 as per the terms and conditions of the offering circular dated May 12, 2006.

Further, Aurobindo Pharma had issued FCCBs aggregating to $50 million (Tranche B) and after repurchase and cancellation of FCCBs from time to time, the outstanding nominal value of FCCBs of $32.95 million has been paid in full at the redemption price of 146.991% of its principal amount on maturity date - May 17, 2011 as per the terms and conditions of the offering circular dated May 12, 2006.

The company has paid an aggregate amount of $203.86 million for both aforesaid tranches at the time of redemption. Pursuant to this all bonds issued by the company in May 2006 have been extinguished in full and there are no outstanding as on date.

Aurobindo Pharma is the market leader in semi-synthetic penicillin drugs. It has presence in key therapeutic segments like SSPs, cephalosporins, anti-retrovirals, CNS, cardio-vascular, gastroenterology, etc.

Aurobindo Pharma Share Price

1480.40 -3.00 (-0.20%)
07-May-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1835.25
Dr. Reddys Lab 1306.55
Cipla 1362.95
Zydus Lifesciences 941.35
Lupin 2455.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×